Achievements
Products Presently Marketed
Marketing and Commercialization of 67 SKU’s on 4 Continents Worldwide sales organization for B2B through E-commerce www.pharmasourcing.com
CardioVision™
Preliminary validation of the 9000 CardioVision™ vials for Isotope marking with Tc 99m and Antibody~Antigen binding. Concept Validation for Diagnostic properties of the Product, value in Risk Stratification, value in Heart Transplant Rejection monitoring, Stem Cell Therapy. Re-validation of IND's with TPP and FDA. Contacts with Phase III Clinical Investigators. Contact with CRO (MDS Harris/Phoenix) concerning the Status of ongoing Phase III Trials. Positioning of CardioVision™/ Myocardial Infarction through examination of the existing Dossier, Market Analysis, O.L.-inquiry, compilation of the Business Plan.
Start-Up of New Projects
New Research Techniques and Product development through ProFuMab. |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||